Last Tango in Cyberspace
Corporations pay them top dollar to spot cultural trends before they emerge. Lion Zorn, the first known em-tracker, has done especially well. But he never expected Big Pharma to come calling. In 2025, technology has made massive leaps forward—leaps that can easily be exploited for ignoble ends. Artic Pharmaceuticals has a new drug and a bad idea. All they need now is a formula. But to get it,